Matches in Wikidata for { <http://www.wikidata.org/entity/Q85049476> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q85049476 description "article scientifique publié en 2011" @default.
- Q85049476 description "artículu científicu espublizáu n'ochobre de 2011" @default.
- Q85049476 description "scientific article published on 05 October 2011" @default.
- Q85049476 description "wetenschappelijk artikel" @default.
- Q85049476 description "наукова стаття, опублікована в жовтні 2011" @default.
- Q85049476 name "Phase I/II and pharmacodynamic study of dovitinib (TKI258), an inhibitor of fibroblast growth factor receptors and VEGF receptors, in patients with advanced melanoma" @default.
- Q85049476 name "Phase I/II and pharmacodynamic study of dovitinib (TKI258), an inhibitor of fibroblast growth factor receptors and VEGF receptors, in patients with advanced melanoma" @default.
- Q85049476 type Item @default.
- Q85049476 label "Phase I/II and pharmacodynamic study of dovitinib (TKI258), an inhibitor of fibroblast growth factor receptors and VEGF receptors, in patients with advanced melanoma" @default.
- Q85049476 label "Phase I/II and pharmacodynamic study of dovitinib (TKI258), an inhibitor of fibroblast growth factor receptors and VEGF receptors, in patients with advanced melanoma" @default.
- Q85049476 prefLabel "Phase I/II and pharmacodynamic study of dovitinib (TKI258), an inhibitor of fibroblast growth factor receptors and VEGF receptors, in patients with advanced melanoma" @default.
- Q85049476 prefLabel "Phase I/II and pharmacodynamic study of dovitinib (TKI258), an inhibitor of fibroblast growth factor receptors and VEGF receptors, in patients with advanced melanoma" @default.
- Q85049476 P1433 Q85049476-6A5E54B9-61C9-4D13-9A1A-3C894838EF1C @default.
- Q85049476 P1476 Q85049476-C9FCCC60-E208-418E-98C4-503617A25F7E @default.
- Q85049476 P2093 Q85049476-06B1B788-20E3-431F-B0E0-CCB089DCB3B0 @default.
- Q85049476 P2093 Q85049476-4F25AB9A-503E-4857-A8B4-77D8CEE31111 @default.
- Q85049476 P2093 Q85049476-701DB5DB-3DC9-47BB-8184-5DCF5EBF250E @default.
- Q85049476 P2093 Q85049476-77F13458-36A8-4594-87B8-B13D7CB0CA06 @default.
- Q85049476 P2093 Q85049476-81EF9C6A-C361-4DAB-ACF5-8A47DA3859C0 @default.
- Q85049476 P2093 Q85049476-B8922BFE-BF30-4121-8B7F-2AB7CF690D78 @default.
- Q85049476 P304 Q85049476-DAEEE5BA-7451-499F-8813-B0C3318253DA @default.
- Q85049476 P31 Q85049476-26D78726-3819-4B5F-8498-DCB8EA12F02B @default.
- Q85049476 P356 Q85049476-9F70A295-7877-4F2A-A059-573F76E2AA68 @default.
- Q85049476 P433 Q85049476-943B58AE-6A73-48EC-81C8-A79133425023 @default.
- Q85049476 P478 Q85049476-38798C43-E159-4E7D-B109-E5F864956043 @default.
- Q85049476 P577 Q85049476-A32550D2-0B28-431F-87D3-95B8E87E52ED @default.
- Q85049476 P698 Q85049476-1AE699F9-CC85-42A7-8C81-B761CA0750EB @default.
- Q85049476 P921 Q85049476-97110F4B-78C1-4EEB-86AE-0832297C2EAE @default.
- Q85049476 P356 1078-0432.CCR-11-1747 @default.
- Q85049476 P698 21976540 @default.
- Q85049476 P1433 Q332253 @default.
- Q85049476 P1476 "Phase I/II and pharmacodynamic study of dovitinib (TKI258), an inhibitor of fibroblast growth factor receptors and VEGF receptors, in patients with advanced melanoma" @default.
- Q85049476 P2093 "Douglas Robinson" @default.
- Q85049476 P2093 "Humphrey Gardner" @default.
- Q85049476 P2093 "Jason Chesney" @default.
- Q85049476 P2093 "John M Kirkwood" @default.
- Q85049476 P2093 "Kevin B Kim" @default.
- Q85049476 P2093 "Michael M Shi" @default.
- Q85049476 P304 "7451-7461" @default.
- Q85049476 P31 Q13442814 @default.
- Q85049476 P356 "10.1158/1078-0432.CCR-11-1747" @default.
- Q85049476 P433 "23" @default.
- Q85049476 P478 "17" @default.
- Q85049476 P577 "2011-10-05T00:00:00Z" @default.
- Q85049476 P698 "21976540" @default.
- Q85049476 P921 Q725307 @default.